Joseph D Teller

Title: Joseph D Teller: Innovator in Pyrogen Testing

Introduction

Joseph D Teller is a notable inventor based in Freehold, NJ (US). He has made significant contributions to the field of biomedical testing, particularly in the detection of endotoxins in aqueous solutions. His innovative approach has implications for the safety of parenterally-administered drugs.

Latest Patents

Joseph D Teller holds a patent for the "Limulus lysate turbidity test for pyrogens." This patent describes a method for determining the endotoxin content in aqueous liquids by using lysate obtained from the blood of the horseshoe crab (Limulus polyphemus). The process involves admixing a sample of the liquid with the lysate, which is buffered to a specific pH and concentration. The resulting turbidity is measured to quantify the endotoxin content, providing both qualitative and quantitative results.

Career Highlights

Joseph D Teller is associated with Worthington Biochemical Corporation, where he applies his expertise in biochemical testing. His work has contributed to advancements in ensuring the safety and efficacy of pharmaceutical products. His innovative methods have been recognized within the industry for their reliability and accuracy.

Collaborations

Joseph has collaborated with Kristine M Kelly, working together to enhance the development and application of pyrogen testing methods. Their partnership has fostered advancements in the field, leading to improved testing protocols.

Conclusion

Joseph D Teller's contributions to pyrogen testing exemplify the importance of innovation in ensuring drug safety. His work continues to impact the biomedical field positively, showcasing the vital role of inventors in advancing healthcare technologies.